Is it necessary to apply for approval of international cooperative scientific research if the involving parties of ongoing clinical trial project change to foreign entities?

If it is necessary to apply for the approval of international cooperative scientific research, the project shall be suspended first, and can be continued only after the approval of international cooperative scientific research.

Suggested Reading

How should the evaluation of new items in the endpoint table be considered after the implementation of the new…
Can products made from materials conforming to YY 0341.1 Appendix B be exempted from biological evaluation?
What are the key focus areas in the evaluation of acute, subacute, subchronic, and chronic toxicity, and can…
Under what conditions can the extraction liquid of dressings be accepted after pH adjustment, centrifugation,…
When combining subchronic and implantation tests in one project, what factors need to be considered, and how can…
Do all medical devices require chemical characterization?
What factors may affect biocompatibility risk when using biological test data from similar devices for…
How is the endotoxin limit for wound dressing products determined?
GB/T 16886.11-2021 adds tests for subchronic systemic toxicity evaluation with dual-route exposure. Which…
GB/T 16886.1-2022 includes implantation in the biological evaluation of dressings. How should implantation tests…
Why is the extraction period typically 24 hours in China for cytotoxicity testing?
For subchronic systemic toxicity studied via implantation, what is the basis for determining the implantation…

Is It Necessary To Apply For Approval Of International Cooperative Scientific Research If The Involving Parties Of Ongoing Clinical Trial Project Change To Foreign Entities?

Suggested Reading